Advertisement
Canada markets open in 5 hours 29 minutes

  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CAD/USD

    0.7299
    -0.0002 (-0.03%)
     

  • CRUDE OIL

    82.40
    +0.50 (+0.61%)
     

  • Bitcoin CAD

    90,587.56
    +117.38 (+0.13%)
     

  • CMC Crypto 200

    1,393.78
    -20.98 (-1.48%)
     

  • GOLD FUTURES

    2,324.60
    -21.80 (-0.93%)
     

  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     

  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     

  • NASDAQ futures

    17,359.25
    +9.25 (+0.05%)
     

  • VOLATILITY

    16.68
    -0.26 (-1.53%)
     

  • FTSE

    8,058.67
    +34.80 (+0.43%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6834
    -0.0016 (-0.23%)
     

Five Star Equities Issues New Research Reports on ATHN, CIEN, FB and SUNE

ACCESSWIRE

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Athenahealth, Inc. (NASDAQ:ATHN - News) shares declined 3.25 percent to close at $126.60 a share Thursday. The stock traded between $122.70 and $133.12 on volume of 3.14 million shares traded. The company expects revenues in the range of $725.0 million to $755.0 million for 2014, which fell short of analysts’ forecast of $760.1 million, according to FactSet. Shares of Athenahealth have gained approximately 70.0 percent year-to-date.

Get more information on Athenahealth and free access to the in-depth equity report at:
www.FiveStarEquities.com/ATHN

Ciena Corporation (NASDAQ:CIEN - News) shares declined 6.94 percent to close at $21.31 a share Thursday. The stock traded between $20.93 and $22.50 on volume 19.73 million shares traded. The company reported an adjusted net income of $18.3 million, or $0.16 per diluted common share, for the fourth quarter of fiscal 2013, which fell short of analysts’ estimates of $0.24 a share. Shares of Ciena have gained approximately 35.0 percent year-to-date.

ADVERTISEMENT

Get more information on Ciena and free access to the in-depth equity report at: www.FiveStarEquities.com/CIEN

Facebook Inc. (NASDAQ:FB - News) shares spiked 4.96 percent to close at $51.83 a share Thursday. The stock traded between $50.66 and $51.98 on volume 92.30 million shares traded. The company is set to replace The Williams Companies Inc. in the S&P 100 and will also replace Teradyne Inc. in the S&P 500. Shares of Facebook have gained approximately 95.0 percent year-to-date.

Get more information on Facebook and free access to the in-depth equity report at:
www.FiveStarEquities.com/FB

Sunedison Inc. (NYSE:SUNE - News) shares declined 10.16 percent to close at $11.49 a share Thursday. The stock traded between $11.34 and $12.30 on volume 36.14 million shares traded. The company has lowered its forecast for fourth quarter Semiconductor Materials revenue to a range of $205.0 million to $215.0 million, down from its previous forecast of $220.0 million to $230.0 million. Shares of Sunedison have gained approximately 265.0 percent year-to-date.

Get more information on Sunedison and free access to the in-depth equity report at:
www.FiveStarEquities.com/SUNE

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com